193 related articles for article (PubMed ID: 26455864)
1. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations.
Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR
Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864
[TBL] [Abstract][Full Text] [Related]
2. Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis.
Zhu R; Liu X; He Z
Curr Alzheimer Res; 2017; 14(3):335-344. PubMed ID: 27829337
[TBL] [Abstract][Full Text] [Related]
3. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
4. Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population.
Tan L; Yu JT; Zhang W; Wu ZC; Zhang Q; Liu QY; Wang W; Wang HF; Ma XY; Cui WZ
Alzheimers Dement; 2013 Sep; 9(5):546-53. PubMed ID: 23232270
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease.
Deng YL; Liu LH; Wang Y; Tang HD; Ren RJ; Xu W; Ma JF; Wang LL; Zhuang JP; Wang G; Chen SD
Hum Genet; 2012 Jul; 131(7):1245-9. PubMed ID: 22382309
[TBL] [Abstract][Full Text] [Related]
6. CD33 rs3865444 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Chinese, European, and North American Populations.
Li X; Shen N; Zhang S; Liu J; Jiang Q; Liao M; Feng R; Zhang L; Wang G; Ma G; Zhou H; Chen Z; Jiang Y; Zhao B; Li K; Liu G
Mol Neurobiol; 2015 Aug; 52(1):414-21. PubMed ID: 25186233
[TBL] [Abstract][Full Text] [Related]
7. Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population.
Yuan Q; Chu C; Jia J
Neurol Sci; 2012 Oct; 33(5):1021-8. PubMed ID: 22167654
[TBL] [Abstract][Full Text] [Related]
8. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
[TBL] [Abstract][Full Text] [Related]
9. CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
Tian Q; Sun X; Li C; Yang Y; Hou B; Xie A
Neurosci Lett; 2023 Aug; 812():137400. PubMed ID: 37479176
[TBL] [Abstract][Full Text] [Related]
10. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
11. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility.
Raj T; Ryan KJ; Replogle JM; Chibnik LB; Rosenkrantz L; Tang A; Rothamel K; Stranger BE; Bennett DA; Evans DA; De Jager PL; Bradshaw EM
Hum Mol Genet; 2014 May; 23(10):2729-36. PubMed ID: 24381305
[TBL] [Abstract][Full Text] [Related]
12. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer's Disease.
Heidari F; Ansstas G; Ajamian F
Gerontology; 2022; 68(4):421-430. PubMed ID: 34569532
[TBL] [Abstract][Full Text] [Related]
13. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Hollingworth P; Harold D; Sims R; Gerrish A; Lambert JC; Carrasquillo MM; Abraham R; Hamshere ML; Pahwa JS; Moskvina V; Dowzell K; Jones N; Stretton A; Thomas C; Richards A; Ivanov D; Widdowson C; Chapman J; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Holmes C; Mann D; Smith AD; Beaumont H; Warden D; Wilcock G; Love S; Kehoe PG; Hooper NM; Vardy ER; Hardy J; Mead S; Fox NC; Rossor M; Collinge J; Maier W; Jessen F; Rüther E; Schürmann B; Heun R; Kölsch H; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Gallacher J; Hüll M; Rujescu D; Giegling I; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Sleegers K; Bettens K; Engelborghs S; De Deyn PP; Van Broeckhoven C; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Pankratz VS; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Dickson DW; Graff-Radford NR; Petersen RC; ; van Duijn CM; Breteler MM; Ikram MA; DeStefano AL; Fitzpatrick AL; Lopez O; Launer LJ; Seshadri S; ; Berr C; Campion D; Epelbaum J; Dartigues JF; Tzourio C; Alpérovitch A; Lathrop M; ; Feulner TM; Friedrich P; Riehle C; Krawczak M; Schreiber S; Mayhaus M; Nicolhaus S; Wagenpfeil S; Steinberg S; Stefansson H; Stefansson K; Snaedal J; Björnsson S; Jonsson PV; Chouraki V; Genier-Boley B; Hiltunen M; Soininen H; Combarros O; Zelenika D; Delepine M; Bullido MJ; Pasquier F; Mateo I; Frank-Garcia A; Porcellini E; Hanon O; Coto E; Alvarez V; Bosco P; Siciliano G; Mancuso M; Panza F; Solfrizzi V; Nacmias B; Sorbi S; Bossù P; Piccardi P; Arosio B; Annoni G; Seripa D; Pilotto A; Scarpini E; Galimberti D; Brice A; Hannequin D; Licastro F; Jones L; Holmans PA; Jonsson T; Riemenschneider M; Morgan K; Younkin SG; Owen MJ; O'Donovan M; Amouyel P; Williams J
Nat Genet; 2011 May; 43(5):429-35. PubMed ID: 21460840
[TBL] [Abstract][Full Text] [Related]
14. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
Ebbert MTW; Boehme KL; Wadsworth ME; Staley LA; ; ; Mukherjee S; Crane PK; Ridge PG; Kauwe JSK
Alzheimers Dement; 2016 Feb; 12(2):121-129. PubMed ID: 26449541
[TBL] [Abstract][Full Text] [Related]
15. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
16. The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease.
Huang J; Tao Q; Ang TFA; Farrell J; Zhu C; Wang Y; Stein TD; Lunetta KL; Massaro J; Mez J; Au R; Farrer LA; Qiu WQ; Zhang X;
Transl Psychiatry; 2022 Dec; 12(1):523. PubMed ID: 36550123
[TBL] [Abstract][Full Text] [Related]
17. CD33 rs3865444 as a risk factor for Parkinson's disease.
Siokas V; Arseniou S; Aloizou AM; Tsouris Z; Liampas I; Sgantzos M; Liakos P; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
Neurosci Lett; 2021 Mar; 748():135709. PubMed ID: 33582190
[TBL] [Abstract][Full Text] [Related]
18. Effects of CD33 Variants on Neuroimaging Biomarkers in Non-Demented Elders.
Wang YJ; Wan Y; Wang HF; Tan CC; Li JQ; Yu JT; Tan L;
J Alzheimers Dis; 2019; 68(2):757-766. PubMed ID: 30883353
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis.
Bao J; Wang XJ; Mao ZF
Med Sci Monit; 2016 Jan; 22():234-43. PubMed ID: 26795201
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the association between
Jiang YT; Li HY; Cao XP; Tan L
Ann Transl Med; 2018 May; 6(10):169. PubMed ID: 29951491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
